SCHEMBL6942243

SCHEMBL6942243

COc1ccc(S(=O)(=O)NNC(=O)[C@H](CC(C)C)[C@H](CC=Cc2ccccc2)C(=O)NOC2CCCCO2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 1/20 0.40
MMP1 P03956 4/20 0.37
MMP13 P45452 3/20 0.37
MMP9 P14780 1/20 0.37
HTT P42858 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
GAA P10253 4/20 0.36
BCAT1 P54687 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
KDM4E B2RXH2 2/20 0.34
LMNA P02545 5/20 0.34
MAPK1 P28482 2/20 0.34
KCNA5 P22460 1/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6937845 0.88 ADAM17 (0.46) ADAM17MMP1MMP9GAAALDH1A1
SCHEMBL6947400 0.88 ADAM17 (0.46) ADAM17MMP1MMP9GAAALDH1A1
SCHEMBL6940024 0.84 ADAM17 (0.48) ADAM17MMP1MMP13MMP9SMN1; SMN2
SCHEMBL6947186 0.83 ADAM17 (0.52) ADAM17MMP1MMP13MMP9HTT
SCHEMBL6983937 0.83 ADAM17 (0.42) ADAM17MMP9ALDH1A1MMP2GRIK1
SCHEMBL7955132 0.83 ADAM17 (0.44) ADAM17MMP9ALDH1A1MMP2GRIK1
SCHEMBL7835552 0.83 ADAM17 (0.44) ADAM17MMP9ALDH1A1MMP2GRIK1
SCHEMBL6941116 0.83 ADAM17 (0.56) ADAM17MMP1MMP13MMP9HTT
SCHEMBL6943375 0.81 ADAM17 (0.53) ADAM17MMP1MMP13MMP9GAA
SCHEMBL6946530 0.80 ADAM17 (0.40) ADAM17MMP1MMP13MMP9MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0993442-B1 HYDRAZINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2003-04-23 EP disclosed
US-6235787-B1 ANTIINFLAMMATORY AGENTS; RHEUMATIC DISEASES; BONE DISORDERS; SKIN DISORDERS; MULTIPLE SCLEROSIS HOFFMANN-LA ROCHE INC. 2001-05-22 US disclosed